Report Detail
Global Cancer Therapeutics and Supportive Care Drugs Market Insights, Forecast to 2025
- RnM2708132 |
- 06 May, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life. The key indications covered in this report are cancer pain, oral mucositis, chemotherapy-induced neutropenia (CIN), chemotherapy-induced anemia (CIA), chemotherapy-induced nausea and vomiting (CINV) and bone metastasis. These indications are not only distressing for patients, but can also lead to treatment cessation, which in turn increases patient mortality. As the number of people being diagnosed with cancer grows and access to effective treatment that allows patients to survive longer increases, demand for safe and effective cancer supportive care drugs will rise.
The global Cancer Therapeutics and Supportive Care Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of 9.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cancer Therapeutics and Supportive Care Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Cancer Therapeutics and Supportive Care Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cancer Therapeutics and Supportive Care Drugs in these regions.
This research report categorizes the global Cancer Therapeutics and Supportive Care Drugs market by top players/brands, region, type and end user. This report also studies the global Cancer Therapeutics and Supportive Care Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbott Laboratories
AstraZeneca plc
Astellas Pharma
Bristol-Myers Squibb
Johnson & Johnson
Eli Lilly
Novartis
Pfizer
Sanofi
Teva Pharmaceuticals
Takeda Pharmaceuticals
AbbVie
Market size by Product
Cancer Therapeutics
Supportive Care Drugs
Market size by End User
Hospital
Retail
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Cancer Therapeutics and Supportive Care Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cancer Therapeutics and Supportive Care Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cancer Therapeutics and Supportive Care Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cancer Therapeutics and Supportive Care Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Cancer Therapeutics and Supportive Care Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cancer Therapeutics and Supportive Care Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Cancer Therapeutics and Supportive Care Drugs Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Cancer Therapeutics and Supportive Care Drugs Market Size Growth Rate by Product
- 1.4.2 Cancer Therapeutics
- 1.4.3 Supportive Care Drugs
- 1.5 Market by End User
- 1.5.1 Global Cancer Therapeutics and Supportive Care Drugs Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Retail
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Cancer Therapeutics and Supportive Care Drugs Market Size
- 2.1.1 Global Cancer Therapeutics and Supportive Care Drugs Revenue 2014-2025
- 2.1.2 Global Cancer Therapeutics and Supportive Care Drugs Sales 2014-2025
- 2.2 Cancer Therapeutics and Supportive Care Drugs Growth Rate by Regions
- 2.2.1 Global Cancer Therapeutics and Supportive Care Drugs Sales by Regions
- 2.2.2 Global Cancer Therapeutics and Supportive Care Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Cancer Therapeutics and Supportive Care Drugs Sales by Manufacturers
- 3.1.1 Cancer Therapeutics and Supportive Care Drugs Sales by Manufacturers
- 3.1.2 Cancer Therapeutics and Supportive Care Drugs Sales Market Share by Manufacturers
- 3.1.3 Global Cancer Therapeutics and Supportive Care Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Cancer Therapeutics and Supportive Care Drugs Revenue by Manufacturers
- 3.2.1 Cancer Therapeutics and Supportive Care Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Cancer Therapeutics and Supportive Care Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 Cancer Therapeutics and Supportive Care Drugs Price by Manufacturers
- 3.4 Cancer Therapeutics and Supportive Care Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Cancer Therapeutics and Supportive Care Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Cancer Therapeutics and Supportive Care Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Cancer Therapeutics and Supportive Care Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Cancer Therapeutics and Supportive Care Drugs Sales by Product
- 4.2 Global Cancer Therapeutics and Supportive Care Drugs Revenue by Product
- 4.3 Cancer Therapeutics and Supportive Care Drugs Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Cancer Therapeutics and Supportive Care Drugs Breakdown Data by End User
6 North America
- 6.1 North America Cancer Therapeutics and Supportive Care Drugs by Countries
- 6.1.1 North America Cancer Therapeutics and Supportive Care Drugs Sales by Countries
- 6.1.2 North America Cancer Therapeutics and Supportive Care Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Cancer Therapeutics and Supportive Care Drugs by Product
- 6.3 North America Cancer Therapeutics and Supportive Care Drugs by End User
7 Europe
- 7.1 Europe Cancer Therapeutics and Supportive Care Drugs by Countries
- 7.1.1 Europe Cancer Therapeutics and Supportive Care Drugs Sales by Countries
- 7.1.2 Europe Cancer Therapeutics and Supportive Care Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Cancer Therapeutics and Supportive Care Drugs by Product
- 7.3 Europe Cancer Therapeutics and Supportive Care Drugs by End User
8 Asia Pacific
- 8.1 Asia Pacific Cancer Therapeutics and Supportive Care Drugs by Countries
- 8.1.1 Asia Pacific Cancer Therapeutics and Supportive Care Drugs Sales by Countries
- 8.1.2 Asia Pacific Cancer Therapeutics and Supportive Care Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Cancer Therapeutics and Supportive Care Drugs by Product
- 8.3 Asia Pacific Cancer Therapeutics and Supportive Care Drugs by End User
9 Central & South America
- 9.1 Central & South America Cancer Therapeutics and Supportive Care Drugs by Countries
- 9.1.1 Central & South America Cancer Therapeutics and Supportive Care Drugs Sales by Countries
- 9.1.2 Central & South America Cancer Therapeutics and Supportive Care Drugs Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Cancer Therapeutics and Supportive Care Drugs by Product
- 9.3 Central & South America Cancer Therapeutics and Supportive Care Drugs by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Cancer Therapeutics and Supportive Care Drugs by Countries
- 10.1.1 Middle East and Africa Cancer Therapeutics and Supportive Care Drugs Sales by Countries
- 10.1.2 Middle East and Africa Cancer Therapeutics and Supportive Care Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Cancer Therapeutics and Supportive Care Drugs by Product
- 10.3 Middle East and Africa Cancer Therapeutics and Supportive Care Drugs by End User
11 Company Profiles
- 11.1 Abbott Laboratories
- 11.1.1 Abbott Laboratories Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Abbott Laboratories Cancer Therapeutics and Supportive Care Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Abbott Laboratories Cancer Therapeutics and Supportive Care Drugs Products Offered
- 11.1.5 Abbott Laboratories Recent Development
- 11.2 AstraZeneca plc
- 11.2.1 AstraZeneca plc Company Details
- 11.2.2 Company Business Overview
- 11.2.3 AstraZeneca plc Cancer Therapeutics and Supportive Care Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 AstraZeneca plc Cancer Therapeutics and Supportive Care Drugs Products Offered
- 11.2.5 AstraZeneca plc Recent Development
- 11.3 Astellas Pharma
- 11.3.1 Astellas Pharma Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Astellas Pharma Cancer Therapeutics and Supportive Care Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Astellas Pharma Cancer Therapeutics and Supportive Care Drugs Products Offered
- 11.3.5 Astellas Pharma Recent Development
- 11.4 Bristol-Myers Squibb
- 11.4.1 Bristol-Myers Squibb Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Bristol-Myers Squibb Cancer Therapeutics and Supportive Care Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Bristol-Myers Squibb Cancer Therapeutics and Supportive Care Drugs Products Offered
- 11.4.5 Bristol-Myers Squibb Recent Development
- 11.5 Johnson & Johnson
- 11.5.1 Johnson & Johnson Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Johnson & Johnson Cancer Therapeutics and Supportive Care Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Johnson & Johnson Cancer Therapeutics and Supportive Care Drugs Products Offered
- 11.5.5 Johnson & Johnson Recent Development
- 11.6 Eli Lilly
- 11.6.1 Eli Lilly Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Eli Lilly Cancer Therapeutics and Supportive Care Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Eli Lilly Cancer Therapeutics and Supportive Care Drugs Products Offered
- 11.6.5 Eli Lilly Recent Development
- 11.7 Novartis
- 11.7.1 Novartis Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Novartis Cancer Therapeutics and Supportive Care Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Novartis Cancer Therapeutics and Supportive Care Drugs Products Offered
- 11.7.5 Novartis Recent Development
- 11.8 Pfizer
- 11.8.1 Pfizer Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Pfizer Cancer Therapeutics and Supportive Care Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Pfizer Cancer Therapeutics and Supportive Care Drugs Products Offered
- 11.8.5 Pfizer Recent Development
- 11.9 Sanofi
- 11.9.1 Sanofi Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Sanofi Cancer Therapeutics and Supportive Care Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Sanofi Cancer Therapeutics and Supportive Care Drugs Products Offered
- 11.9.5 Sanofi Recent Development
- 11.10 Teva Pharmaceuticals
- 11.10.1 Teva Pharmaceuticals Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Teva Pharmaceuticals Cancer Therapeutics and Supportive Care Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Teva Pharmaceuticals Cancer Therapeutics and Supportive Care Drugs Products Offered
- 11.10.5 Teva Pharmaceuticals Recent Development
- 11.11 Takeda Pharmaceuticals
- 11.12 AbbVie
12 Future Forecast
- 12.1 Cancer Therapeutics and Supportive Care Drugs Market Forecast by Regions
- 12.1.1 Global Cancer Therapeutics and Supportive Care Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Cancer Therapeutics and Supportive Care Drugs Revenue Forecast by Regions 2019-2025
- 12.2 Cancer Therapeutics and Supportive Care Drugs Market Forecast by Product
- 12.2.1 Global Cancer Therapeutics and Supportive Care Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global Cancer Therapeutics and Supportive Care Drugs Revenue Forecast by Product 2019-2025
- 12.3 Cancer Therapeutics and Supportive Care Drugs Market Forecast by End User
- 12.4 North America Cancer Therapeutics and Supportive Care Drugs Forecast
- 12.5 Europe Cancer Therapeutics and Supportive Care Drugs Forecast
- 12.6 Asia Pacific Cancer Therapeutics and Supportive Care Drugs Forecast
- 12.7 Central & South America Cancer Therapeutics and Supportive Care Drugs Forecast
- 12.8 Middle East and Africa Cancer Therapeutics and Supportive Care Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Cancer Therapeutics and Supportive Care Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Cancer Therapeutics and Supportive Care Drugs . Industry analysis & Market Report on Cancer Therapeutics and Supportive Care Drugs is a syndicated market report, published as Global Cancer Therapeutics and Supportive Care Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Cancer Therapeutics and Supportive Care Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
